211 related articles for article (PubMed ID: 26534724)
21. Taurine Administration Mitigates Cisplatin Induced Acute Nephrotoxicity by Decreasing DNA Damage and Inflammation: An Immunocytochemical Study.
Tsunekawa M; Wang S; Kato T; Yamashita T; Ma N
Adv Exp Med Biol; 2017; 975 Pt 2():703-716. PubMed ID: 28849493
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity in mice: a comparative study.
Yapar K; Cavuşoğlu K; Oruç E; Yalçin E
J Med Food; 2009 Oct; 12(5):1136-42. PubMed ID: 19857080
[TBL] [Abstract][Full Text] [Related]
23. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
Najjar TA; Saad SY
Chemotherapy; 2001; 47(2):128-35. PubMed ID: 11173815
[TBL] [Abstract][Full Text] [Related]
24. Population Pharmacokinetic-Toxicodynamic Modeling and Simulation of Cisplatin-Induced Acute Renal Injury in Rats: Effect of Dosing Rate on Nephrotoxicity.
Fukushima K; Okada A; Sasaki K; Kishimoto S; Fukushima S; Hamori M; Nishimura A; Shibata N; Shirai T; Terauchi R; Kubo T; Sugioka N
J Pharm Sci; 2016 Jan; 105(1):324-32. PubMed ID: 26852862
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
Saad SY; Najjar TA; Daba MH; Al-Rikabi AC
Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106
[TBL] [Abstract][Full Text] [Related]
26. Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice.
Kimura T; Nojiri T; Hosoda H; Ishikane S; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
Cancer Chemother Pharmacol; 2015 May; 75(5):1057-63. PubMed ID: 25814217
[TBL] [Abstract][Full Text] [Related]
27. In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells.
Sohn SJ; Kim SY; Kim HS; Chun YJ; Han SY; Kim SH; Moon A
Toxicol Lett; 2013 Mar; 217(3):235-42. PubMed ID: 23287709
[TBL] [Abstract][Full Text] [Related]
28. The aqueous extract of cinnamon bark ameliorated cisplatin-induced cytotoxicity in vero cells without compromising the anticancer efficiency of cisplatin.
ElKady AI; Ramadan WS
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):363-71. PubMed ID: 27465514
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the nephroprotective effects of non-steroidal anti-inflammatory drugs on cisplatin-induced nephrotoxicity in vitro and in vivo.
Okamoto K; Saito Y; Narumi K; Furugen A; Iseki K; Kobayashi M
Eur J Pharmacol; 2020 Oct; 884():173339. PubMed ID: 32726655
[TBL] [Abstract][Full Text] [Related]
30. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha.
Ramesh G; Reeves WB
Kidney Int; 2004 Feb; 65(2):490-9. PubMed ID: 14717919
[TBL] [Abstract][Full Text] [Related]
31. Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study.
Komaki K; Kusaba T; Tanaka M; Kado H; Shiotsu Y; Matsui M; Shiozaki A; Nakano H; Ishikawa T; Fujiwara H; Konishi H; Itoh Y; Matoba S; Tamagaki K
BMC Cancer; 2017 Feb; 17(1):144. PubMed ID: 28219368
[TBL] [Abstract][Full Text] [Related]
32. Risk Factors Associated with Cisplatin-Induced Nephrotoxicity in Patients with Advanced Lung Cancer.
Miyoshi T; Misumi N; Hiraike M; Mihara Y; Nishino T; Tsuruta M; Kawamata Y; Hiraki Y; Kozono A; Ichiki M
Biol Pharm Bull; 2016; 39(12):2009-2014. PubMed ID: 27904042
[TBL] [Abstract][Full Text] [Related]
33. Alterations in Cisplatin Pharmacokinetics and Its Acute/Sub-chronic Kidney Injury over Multiple Cycles of Cisplatin Treatment in Rats.
Okada A; Fukushima K; Fujita M; Nakanishi M; Hamori M; Nishimura A; Shibata N; Sugioka N
Biol Pharm Bull; 2017; 40(11):1948-1955. PubMed ID: 29093343
[TBL] [Abstract][Full Text] [Related]
34. Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats.
Abdel-Daim MM; El-Sayed YS; Eldaim MA; Ibrahim A
Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):301-309. PubMed ID: 27975300
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 deficiency accelerates cisplatin-induced acute renal failure but not systemic injury.
Mitazaki S; Kato N; Suto M; Hiraiwa K; Abe S
Toxicology; 2009 Nov; 265(3):115-21. PubMed ID: 19833167
[TBL] [Abstract][Full Text] [Related]
36. Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy.
Chiang CS; Tseng YH; Liao BJ; Chen SY
Adv Healthc Mater; 2015 May; 4(7):1066-75. PubMed ID: 25656800
[TBL] [Abstract][Full Text] [Related]
37. A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury Biomarkers.
Chen L; Smith J; Mikl J; Fryer R; Pack F; Williams BJ; Phillips JA; Papov VV
Chem Res Toxicol; 2017 Oct; 30(10):1823-1834. PubMed ID: 28885000
[TBL] [Abstract][Full Text] [Related]
38. Astilbin ameliorates cisplatin-induced nephrotoxicity through reducing oxidative stress and inflammation.
Wang SW; Xu Y; Weng YY; Fan XY; Bai YF; Zheng XY; Lou LJ; Zhang F
Food Chem Toxicol; 2018 Apr; 114():227-236. PubMed ID: 29471006
[TBL] [Abstract][Full Text] [Related]
39. Effect of the lipid peroxide reaction caused by repeated cold stress on cisplatin-induced nephrotoxicity.
Namikawa K; Hirai K; Tanaka I; Miyauchi K; Minami T; Okazaki Y
Biol Trace Elem Res; 1998 Sep; 63(3):213-20. PubMed ID: 9840817
[TBL] [Abstract][Full Text] [Related]
40. [Clinical investigation of cis-platinum nephrotoxicity in 244 cases of primary lung cancer].
Soejima A; Inoue T; Suzuki M; Waku M; Nakabayashi K; Kitamoto K; Nagasawa T
Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):801-6. PubMed ID: 1479719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
